Retatrutide

About Retatrutide

Retatrutide is an investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Early Phase 2 clinical data showed unprecedented weight loss of up to 24% of body weight at 48 weeks. This triple-action approach addresses appetite, metabolism, and fat oxidation from three distinct pathways.

Key Benefits

• Triple-Action Mechanism

  Targets GLP-1, GIP, and glucagon receptors for unmatched metabolic coverage.

• Up to 24% Weight Loss

  Early clinical data shows unprecedented results in body weight reduction.

• Enhanced Fat Oxidation

  Glucagon receptor activation directly promotes fat burning.

• Potential Liver Benefits

  May reduce liver fat and improve liver health markers.

How Retatrutide Helps

Retatrutide activates three metabolic pathways simultaneously — suppressing appetite via GLP-1, improving insulin sensitivity via GIP, and promoting fat oxidation via glucagon. This triple action delivers the most comprehensive metabolic intervention available.

How It Works

After you complete the intake, a licensed provider reviews your medical history and goals to determine if Retatrutide is appropriate for you. If approved, your prescription is sent to a partner compounding pharmacy and shipped directly to your door with full dosing instructions and supplies as needed.

Dosage & Administration

Administered via subcutaneous injection as directed by your provider. Detailed injection training and supplies are included with your order. Your provider will personalize the dose and titration schedule for your goals.

Safety & Side Effects

Side effects are generally mild and may include injection-site reactions, mild headache, or temporary GI changes depending on the therapy. Discuss any new symptoms with your provider. Retatrutide is not appropriate for everyone — your provider will screen for contraindications before prescribing.